Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC)

NCT06798454 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Biliary Cholangitis (PBC)

Interventions

DRUG: PVT201
OTHER: Placebo

Sponsor

Parvus Therapeutics, Inc.

Collaborators

[object Object]